Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V116517 biomarker study in healthy males
NCT02695745Phase 1Completed
- Sponsor
- Purdue Pharma
- Start
- Sep 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of V116517 in pain (3 arms), sponsored by Purdue Pharma. Primary endpoint: Heat pain tolerance threshold. Started Sep 2011; status: completed.
02
Drugs
V116517
03
Conditions
pain
Beyond the preview
Go deeper on NCT02695745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695745.